GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

By Maggie Fick and Yamini Kalia (Reuters) -GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a ...

(Reuters) - GSK said on Wednesday it had reached agreements with ten plaintiff firms, representing 93% of U.S. state court ...

GSK has agreed to pay $2.3 billion to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.

We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

Justice Jane Bland asked why the court should not look plaintiffs that step into the shoes of a defendant through a ...

The Bank of England risks inflicting unnecessary damage to the economy by keeping interest rates too high for too long, a ...

Unilever has said that it has divested its Russian business as it leaves the country more than two-and-a-half years into the ...

OC Transpo is extending a crackdown on fare evasion to the end of the year after seeing success during the month of September ...

A stretch of the A66 through Middlesbrough will be closed overnight next week for essential maintenance work. The closure ...

Huge names including Sony Pictures, Pfizer and more will be taking part in the recruitment and networking event The post ...